Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
The independent investigative committee found that a routing mistake by a station master sent a passenger train onto the same ...
US federal health officials and experts say there is no evidence that residual DNA from the COVID-19 vaccines can integrate into human DNA ...
The CDC today doubled down on its recommendation that babies should get the Covid vaccine, even after warnings over injuries ...
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...
Robert F. Kennedy Jr, the newly confirmed health secretary for the Trump administration who has called for sweeping policy ...
15hon MSN
The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest ...
(WIFR) - 2025 marks five years since the deadly COVID-19 pandemic and research shows it impacted how drugs and vaccines are discovered. Phil Mounteney, who is Dotmatics' vice president of science and ...
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results